HEADER GENE REGULATION/INHIBITOR 25-SEP-19 6UFX TITLE WD REPEAT-CONTAINING PROTEIN 5 COMPLEXED WITH N-[(3,5- TITLE 2 DIMETHOXYPHENYL)METHYL]-4'-FLUORO-5-{[(2E)-2-IMINO-3-METHYL-2,3- TITLE 3 DIHYDRO-1H-IMIDAZOL-1-YL]METHYL}-2'-METHYL[1,1'-BIPHENYL]-3- TITLE 4 CARBOXAMIDE (COMPOUND 13) COMPND MOL_ID: 1; COMPND 2 MOLECULE: WD REPEAT-CONTAINING PROTEIN 5; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 32-334; COMPND 5 SYNONYM: BMP2-INDUCED 3-KB GENE PROTEIN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: WDR5, BIG3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, GENE REGULATION-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.A.RIETZ,S.W.FESIK,B.ZHAO REVDAT 4 11-OCT-23 6UFX 1 REMARK REVDAT 3 05-FEB-20 6UFX 1 JRNL REVDAT 2 15-JAN-20 6UFX 1 JRNL REVDAT 1 01-JAN-20 6UFX 0 JRNL AUTH J.TIAN,K.B.TEUSCHER,E.R.AHO,J.R.ALVARADO,J.J.MILLS, JRNL AUTH 2 K.M.MEYERS,R.D.GOGLIOTTI,C.HAN,J.D.MACDONALD,J.SAI,J.G.SHAW, JRNL AUTH 3 J.L.SENSINTAFFAR,B.ZHAO,T.A.RIETZ,L.R.THOMAS,W.G.PAYNE, JRNL AUTH 4 W.J.MOORE,G.M.STOTT,J.KONDO,M.INOUE,R.J.COFFEY,W.P.TANSEY, JRNL AUTH 5 S.R.STAUFFER,T.LEE,S.W.FESIK JRNL TITL DISCOVERY AND STRUCTURE-BASED OPTIMIZATION OF POTENT AND JRNL TITL 2 SELECTIVE WD REPEAT DOMAIN 5 (WDR5) INHIBITORS CONTAINING A JRNL TITL 3 DIHYDROISOQUINOLINONE BICYCLIC CORE. JRNL REF J.MED.CHEM. V. 63 656 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 31858797 JRNL DOI 10.1021/ACS.JMEDCHEM.9B01608 REMARK 2 REMARK 2 RESOLUTION. 2.02 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.15.2_3472 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.02 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.75 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 20848 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.171 REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1040 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.7460 - 3.8517 1.00 2987 164 0.1565 0.1737 REMARK 3 2 3.8517 - 3.0583 1.00 2914 127 0.1537 0.1999 REMARK 3 3 3.0583 - 2.6720 1.00 2831 160 0.1699 0.2038 REMARK 3 4 2.6720 - 2.4279 1.00 2827 164 0.1826 0.2248 REMARK 3 5 2.4279 - 2.2539 1.00 2819 146 0.1866 0.2463 REMARK 3 6 2.2539 - 2.1211 1.00 2849 135 0.1897 0.2428 REMARK 3 7 2.1211 - 2.0150 0.92 2581 144 0.2060 0.2788 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.090 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.09 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6UFX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-SEP-19. REMARK 100 THE DEPOSITION ID IS D_1000244498. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-APR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0-8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.987 REMARK 200 MONOCHROMATOR : DIAMOND(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20876 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 12.10 REMARK 200 R MERGE (I) : 0.16200 REMARK 200 R SYM (I) : 0.10800 REMARK 200 FOR THE DATA SET : 19.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.03500 REMARK 200 R SYM FOR SHELL (I) : 1.03200 REMARK 200 FOR SHELL : 3.410 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3EG6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS OR HEPES OR TRIS-HCL, REMARK 280 PH 6.0-8.0, 0.2 M AMMONIUM ACETATE, 20-30% PEG3350, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.27300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.27300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 39.31250 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 49.44800 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 39.31250 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 49.44800 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 40.27300 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 39.31250 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 49.44800 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 40.27300 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 39.31250 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 49.44800 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10880 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 526 LIES ON A SPECIAL POSITION. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 32 CG CD CE NZ REMARK 470 ASN A 34 CG OD1 ND2 REMARK 470 LYS A 38 CD CE NZ REMARK 470 LYS A 46 CE NZ REMARK 470 LYS A 78 CG CD CE NZ REMARK 470 LYS A 87 CD CE NZ REMARK 470 LYS A 120 CE NZ REMARK 470 LYS A 159 CD CE NZ REMARK 470 LYS A 162 CG CD CE NZ REMARK 470 ARG A 181 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 204 CG CD OE1 NE2 REMARK 470 LYS A 207 NZ REMARK 470 ASP A 211 CG OD1 OD2 REMARK 470 ASP A 212 CG OD1 OD2 REMARK 470 ASP A 213 CG OD1 OD2 REMARK 470 ASN A 214 CG OD1 ND2 REMARK 470 LYS A 227 CG CD CE NZ REMARK 470 LYS A 239 CE NZ REMARK 470 SER A 244 OG REMARK 470 LYS A 247 CG CD CE NZ REMARK 470 LYS A 259 CD CE NZ REMARK 470 LYS A 272 CE NZ REMARK 470 GLN A 289 CD OE1 NE2 REMARK 470 GLN A 298 CD OE1 NE2 REMARK 470 GLU A 322 CD OE1 OE2 REMARK 470 LYS A 331 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 80 -64.60 -105.12 REMARK 500 SER A 99 17.67 58.10 REMARK 500 SER A 141 27.08 49.92 REMARK 500 ASP A 212 -70.45 -46.37 REMARK 500 ASN A 214 53.79 -114.05 REMARK 500 LEU A 234 35.11 -76.25 REMARK 500 LYS A 259 -37.36 -131.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Q6S A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6UCS RELATED DB: PDB DBREF 6UFX A 32 334 UNP P61964 WDR5_HUMAN 32 334 SEQADV 6UFX SER A 245 UNP P61964 LYS 245 CONFLICT SEQRES 1 A 303 LYS PRO ASN TYR ALA LEU LYS PHE THR LEU ALA GLY HIS SEQRES 2 A 303 THR LYS ALA VAL SER SER VAL LYS PHE SER PRO ASN GLY SEQRES 3 A 303 GLU TRP LEU ALA SER SER SER ALA ASP LYS LEU ILE LYS SEQRES 4 A 303 ILE TRP GLY ALA TYR ASP GLY LYS PHE GLU LYS THR ILE SEQRES 5 A 303 SER GLY HIS LYS LEU GLY ILE SER ASP VAL ALA TRP SER SEQRES 6 A 303 SER ASP SER ASN LEU LEU VAL SER ALA SER ASP ASP LYS SEQRES 7 A 303 THR LEU LYS ILE TRP ASP VAL SER SER GLY LYS CYS LEU SEQRES 8 A 303 LYS THR LEU LYS GLY HIS SER ASN TYR VAL PHE CYS CYS SEQRES 9 A 303 ASN PHE ASN PRO GLN SER ASN LEU ILE VAL SER GLY SER SEQRES 10 A 303 PHE ASP GLU SER VAL ARG ILE TRP ASP VAL LYS THR GLY SEQRES 11 A 303 LYS CYS LEU LYS THR LEU PRO ALA HIS SER ASP PRO VAL SEQRES 12 A 303 SER ALA VAL HIS PHE ASN ARG ASP GLY SER LEU ILE VAL SEQRES 13 A 303 SER SER SER TYR ASP GLY LEU CYS ARG ILE TRP ASP THR SEQRES 14 A 303 ALA SER GLY GLN CYS LEU LYS THR LEU ILE ASP ASP ASP SEQRES 15 A 303 ASN PRO PRO VAL SER PHE VAL LYS PHE SER PRO ASN GLY SEQRES 16 A 303 LYS TYR ILE LEU ALA ALA THR LEU ASP ASN THR LEU LYS SEQRES 17 A 303 LEU TRP ASP TYR SER SER GLY LYS CYS LEU LYS THR TYR SEQRES 18 A 303 THR GLY HIS LYS ASN GLU LYS TYR CYS ILE PHE ALA ASN SEQRES 19 A 303 PHE SER VAL THR GLY GLY LYS TRP ILE VAL SER GLY SER SEQRES 20 A 303 GLU ASP ASN LEU VAL TYR ILE TRP ASN LEU GLN THR LYS SEQRES 21 A 303 GLU ILE VAL GLN LYS LEU GLN GLY HIS THR ASP VAL VAL SEQRES 22 A 303 ILE SER THR ALA CYS HIS PRO THR GLU ASN ILE ILE ALA SEQRES 23 A 303 SER ALA ALA LEU GLU ASN ASP LYS THR ILE LYS LEU TRP SEQRES 24 A 303 LYS SER ASP CYS HET Q6S A 401 36 HETNAM Q6S N-[(3,5-DIMETHOXYPHENYL)METHYL]-4'-FLUORO-5-{[(2E)-2- HETNAM 2 Q6S IMINO-3-METHYL-2,3-DIHYDRO-1H-IMIDAZOL-1-YL]METHYL}- HETNAM 3 Q6S 2'-METHYL[1,1'-BIPHENYL]-3-CARBOXAMIDE FORMUL 2 Q6S C28 H29 F N4 O3 FORMUL 3 HOH *141(H2 O) SHEET 1 AA1 4 ALA A 36 LEU A 41 0 SHEET 2 AA1 4 ILE A 327 LYS A 331 -1 O ILE A 327 N LEU A 41 SHEET 3 AA1 4 ILE A 315 ALA A 320 -1 N ILE A 316 O TRP A 330 SHEET 4 AA1 4 VAL A 304 CYS A 309 -1 N ALA A 308 O ALA A 317 SHEET 1 AA2 4 VAL A 48 PHE A 53 0 SHEET 2 AA2 4 TRP A 59 SER A 64 -1 O ALA A 61 N LYS A 52 SHEET 3 AA2 4 LEU A 68 GLY A 73 -1 O TRP A 72 N LEU A 60 SHEET 4 AA2 4 PHE A 79 SER A 84 -1 O ILE A 83 N ILE A 69 SHEET 1 AA3 4 ILE A 90 TRP A 95 0 SHEET 2 AA3 4 LEU A 101 SER A 106 -1 O ALA A 105 N SER A 91 SHEET 3 AA3 4 THR A 110 ASP A 115 -1 O TRP A 114 N LEU A 102 SHEET 4 AA3 4 CYS A 121 LYS A 126 -1 O LEU A 122 N ILE A 113 SHEET 1 AA4 4 VAL A 132 PHE A 137 0 SHEET 2 AA4 4 LEU A 143 SER A 148 -1 O VAL A 145 N ASN A 136 SHEET 3 AA4 4 VAL A 153 ASP A 157 -1 O TRP A 156 N ILE A 144 SHEET 4 AA4 4 CYS A 163 LEU A 167 -1 O LEU A 167 N VAL A 153 SHEET 1 AA5 4 VAL A 174 PHE A 179 0 SHEET 2 AA5 4 LEU A 185 SER A 190 -1 O VAL A 187 N HIS A 178 SHEET 3 AA5 4 CYS A 195 ASP A 199 -1 O TRP A 198 N ILE A 186 SHEET 4 AA5 4 CYS A 205 LEU A 209 -1 O LEU A 209 N CYS A 195 SHEET 1 AA6 4 VAL A 217 PHE A 222 0 SHEET 2 AA6 4 TYR A 228 THR A 233 -1 O LEU A 230 N LYS A 221 SHEET 3 AA6 4 THR A 237 ASP A 242 -1 O TRP A 241 N ILE A 229 SHEET 4 AA6 4 LYS A 247 TYR A 252 -1 O LYS A 247 N ASP A 242 SHEET 1 AA7 4 ALA A 264 SER A 267 0 SHEET 2 AA7 4 TRP A 273 SER A 276 -1 O VAL A 275 N ASN A 265 SHEET 3 AA7 4 VAL A 283 ASN A 287 -1 O TYR A 284 N SER A 276 SHEET 4 AA7 4 ILE A 293 LEU A 297 -1 O VAL A 294 N ILE A 285 SITE 1 AC1 16 SER A 49 ALA A 65 GLY A 89 ILE A 90 SITE 2 AC1 16 SER A 91 ASP A 92 PHE A 133 PHE A 149 SITE 3 AC1 16 SER A 175 TYR A 191 TYR A 260 CYS A 261 SITE 4 AC1 16 PHE A 263 ILE A 305 HOH A 522 HOH A 607 CRYST1 78.625 98.896 80.546 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012719 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010112 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012415 0.00000